Association of Pharmaceutical Research is honoured to organize 10th World Conference on Pharmaceutical Science and Drug Manufacturing which will be held on 07th & 08th December 2022 at Dubai, UAE. The theme of the conference is ‘An integrative and holistic approach towards pharma science’. Pharmaceutical industry has a significant role in helping patients to get better through their medication. It helps in discovering and developing new drugs which saves many lives. Many disruptive technologies and emerging trends is going to cause a great impact to the pharmaceutical industry. The Pharmaceutical sector has to embrace these new technologies in order to provide a better health in future and also to focus on digital health. Considering this, APR brings together all the professionals, scientists, doctors, research scholars from pharmaceutical sector to share their thoughts, research works and also to discuss the recent technologies and trends.

Read on pharma-dubai.com

We are very pleased to inform you that, after the grand success of the Biotechnology Congress 2021, we are back with the "10th International Conference on Biotechnology Research", which will be conducted on December 07- 08, 2022, in Dubai, UAE. The conference focuses on the theme "Emerging Technologies and Research in Biotechnology". The conference will be filled with knowledgeable and eminent personalities in the biotechnology field from around the world. Biotechnology Congress 2022 promotes the exchange of novel thoughts and creative ideas amongst academicians, industrialists, students, and research scholars. This platform allows researchers to share their novel research findings through oral and poster presentations, allowing them to freely discuss, debate, and defend their findings for the benefit of all biotechnology stakeholders.

Read on biotechnology.pulsusconference.com

With NHS diagnostic services unable to keep pace with patient demand against the backdrop of ageing imaging equipment and radical structure reform, what market opportunities lie ahead for digital health suppliers and consultancies?

The move to unify clinical imaging through incoming imaging networks backed by £248m of regionwide investment represents a significant shift to improving the accuracy and faster turnaround times on tests and scans. To coincide with the launch of Digital Health Intelligence’s launch of Diagnostics and Clinical Imaging market intelligence service, we’re exploring the market movements, trust-level digital purchasing trends and predictions for the sector. Hear our expert team present analysis from Intelligence’s latest census-level NHS data across clinical imaging and provide comment on where next for the market.

Read on digitalhealth.net

This is the UK’s leading national show exploring the technology being developed for mental health care. Realising the potential of digital therapies to widen access to evidence-based treatments is a key ambition; made more relevant than ever by the pandemic. In the UK there is a rapidly developing mental health technology sector, with a range of different applications and technology types. At times it is difficult to determine which technologies are generic well-being applications and which are evidence based, health and care specific and likely to be prescribed by a doctor. Marketplaces such as the NHS app store have made technology more accessible than ever.

Read on giant.health

To optimize digital technologies, leaders need to integrate their disparate technologies within the clinical ecosystem through CC&C platforms. Hear Dr. Kanter describe an overview of a smart, connected hospital framework to help IT leaders make the most of digital health investments. 

Learning Objectives:

• Identify the critical outcomes of integrating a communication system with multiple sources of data, information and knowledge 
• Create a better work environment and experience for care teams, resulting in a better experience for patients and families 
• Unify healthcare teams and the entire enterprise through smart digital technology integration  

Read on chimecentral.org

In the markets, and perhaps in the world, doom and gloom pervade. Yet science continues to move forward at a stunning pace, with big steps forward in gene editing, oncology, and neuroscience. Come for a look at what is ahead next year, and to take the temperature of the big regulatory and financial issues facing the pharmaceutical industry as well as for a panel featuring STAT reporters and fun, humor, and a good party.

Read on statnews.com

Electronic payments are the preferred method for paying off medical bills for 91% of consumers. Stop making the payment process difficult and register for our latest webinar to learn how to create a better financial experience for your patients. Payments have become frictionless in many different industries that we all enjoy. However, healthcare still sends paper bills every 30 days to collect when a balance is owed. Patients are quickly becoming consumers that are demanding modern conveniences that mirror other industries. In this webinar we will explore the insights and trends to follow, so you can get paid much faster, reduce overhead, and increase patient satisfaction scores.

Read on mend.com

Medical wearables are the next big thing. History will show that FitBit and Apple Watch are just the early primitive devices, and that the next wave of smart medical wearables will revolutionize healthcare and dramatically improve quality of life. What are the next-generation medical wearable technologies? What are the most promising use cases and applications? What are the main challenges right now? What’s on the roadmap of the leading companies and R&D groups? These are the key questions that will drive the discussion at this annual conference. The future is bright for medical wearables -- we invite you to attend this conference to identify emerging technology and application trends, exchange ideas, form new companies, and network with your industry peers.

Read on medwearablesconference.com

Pharmaceutical companies work with many different types of data ranging from commercial sales through to longitudinal patient data. In this webinar, the featured speakers explore the distinct differences and the importance of applying the right methods to ensure data accuracy and maintain business confidence. The panel of industry and data science experts draw from their collective experiences working with clients and real world datasets across the world. They address some of the most common questions clients ask when working with longitudinal patient data. This webinar will be a discussion on navigating the complexity of real-world data (RWD) to help pharma companies maintain a competitive edge driven through real world insights. The team will provide tips for asking the right analytics questions to unlock the true power of real-world data.

Read on xtalks.com

Enhance Your Prediction of PKPD, Accurate Dosing Regime and Immuno-Modulation of LNP for Long-Term Patient Safety and Potency

Following the success of LNP-mRNA vaccines, we have seen an influx of novel types of lipids based nanocarriers over the last 12 months, progress has been made to minimize immuno-toxicity challenges – from maximizing therapeutic window to fine-tuning the immune response. 

The highly anticipated Lipid Nanoparticle Immunogenicity and Toxicity Summit takes place this December to unite 80+ senior leaders as the definitive meeting for clinical pharmacology, immunogenicity, bioanalytical development leaders to stay at the forefront, arming you with practical takeaways and lessons learned.

Across 3 days, we will delve into:

HW220702 LNP Immunogenicity and Toxicity logo Favicon

Immunomodulation strategies to increase the therapeutic window

HW220702 LNP Immunogenicity and Toxicity logo Favicon

Translatable preclinical models to revolutionize clinical relevancy 

HW220702 LNP Immunogenicity and Toxicity logo Favicon

Dosing considerations dependent on your disease indication, route of administration and patient group for improved safety

And much more!

Hear the latest insights and case studies to optimize your prediction of PKPD, accurate dosing regime and immuno-modulation of LNP for long-term patient safety and potency.

Across 3 days, with over 6 hours of networking, this is your must-attend summit in 2022, to join the likes of AstraZeneca, Bristol Myers Squibb, NanoVation Therapeutics, Vertex Pharmaceuticals to lay the foundation for robust immunotoxicity protocols, propelling your novel pipeline growth.

Time: 09:00 to 16:00